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Background 
Stroke is a leading cause of global disease burden.1 The burden of stroke is considerable in low-
middle income countries (LMICs) accounting for 52% of prevalent strokes, 71% stroke-related 
deaths, and 78% of disability-adjusted life years lost, globally.2 LMICs experience up to 23% 
greater incidence of stroke than high-income countries (HICs), and the gap continues to widen.2 
In HICs, the burden of stroke is related to the aging population while in LMICs, stroke occurs in 
younger ages mostly due to the greater prevalence of cardiovascular disease risk factors.3  
Stroke is the leading cause of death, and the leading cause of years of life lost in Vietnam.4 Over 
20 years, the incidence of stroke in Vietnam has increased from 213.58/100,000 person-years in 
1990 to 254.78/100,000 person-years in 2010.2 More than 200,000 people have a new stroke 
each year, leading to 11,000 deaths nationwide.5 In the 2013 Global Burden of Disease Study, 
the proportion of stroke-related mortality in Vietnam accounted for 32% of total deaths and was 
at the upper end of the global range (from 2% in Papua to 35% in Macedonia).6 It is estimated 
that 1.5 million people in Vietnam (1.6% of the population; 2013) are living with the 
consequences of stroke.7 
One of the greatest opportunities to reduce preventable death and disability after stroke is to 
ensure access to evidence-based treatment as recommended in clinical guidelines, such as the use 
of intravenous thrombolysis and prevention medication for risk factors.8 Stroke clinical registries 
that incorporate standardized methods of data collection for processes of hospital care as well as 
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associated outcomes after stroke offer reliable guidance on how to reduce the impact of stroke.9 
In Vietnam, systematic and standardized routine collection of outcome data to provide evidence 
of adherence to clinical guideline recommendations for stroke is unavailable.10  
Our aims were to examine the processes of evidence-based care in hospital and outcomes at 
discharge among patients with acute first-ever stroke, and describe the factors associated with 
these outcomes from a major public hospital in Vietnam that admits approximately 15,000 
strokes per year.  
Methods 
In this study, we included hospitalized patients with first-ever strokes (not including transient 
ischemic stroke) admitted between June 2017 and July 2018 to the stroke unit within the 115 
People’s Hospital - a major public hospital in Vietnam. This is a prospective observational study 
whereby standardized methods of data collection for processes of hospital care and outcomes 
were collected using the REgistry of Stroke Care Quality (RES-Q) system (see https://eso-
stroke.org/res-q/). The RES-Q is a data collection tool of the European Stroke Organization  – 
Enhancing and Accelerating Stroke Treatment (ESO-EAST) Project, a program to improve the 
stroke care system (see https://www.qualityregistry.eu/).  
Study factors 
A wide range of factors was recorded in the RES-Q registry, including patient characteristics and 
care received in hospital.11 The factors investigated in the study included (1) socio-
demographics: age, sex; (2) health behaviors/comorbidities: presence of atrial fibrillation, 
smoking status; (3) stroke-related factors: stroke severity assessed by the National Institutes of 
Health Stroke Scale (NIHSS), stroke type, in-hospital stroke (stroke occurred during an episode 
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of admitted patient care for a different condition), time from stroke onset to hospital arrival, and 
door-to-needle time for intravenous thrombolysis; (4) discharge information: length of hospital 
stay and discharge destination; and (5) evidence-based processes of care provided while in 
hospital. The obtained information on hospital care included level-1 evidence-based processes of 
care according to clinical guidelines:12,13   
Outcome measurement 
In-hospital mortality was obtained from the patient medical records. Functional outcome at 
discharge was indicated by the ability to walk 10 meters without assistance at time of discharge. 
Statistical analysis 
Statistical analyses were performed using Stata 12.1 (StataCorp Texas, 2011).14 All two-tailed p-
values ≤0.05 were considered statistically significant.  
We examined the differences in patient characteristics, processes of care, and outcomes using the 
χ2 test for categorical variables (e.g. stroke type) and t test or Wilcoxon signed-rank sum test, as 
appropriate for continuous variables (e.g. age, NIHSS score). Some medication restrictions may 
be appropriate given contraindications or to meet treatment guidelines.13 We assumed that those 
presenting at hospital ≤3.5 hours of stroke onset needed about one additional hour for decision 
processes to occur to be eligible for thrombolysis treatment4.5 hours window after acute IS).15 
Missing data on processes of care were coded as not receiving the corresponding therapy.  
We investigated factors that contributed to in-hospital mortality and functional outcome at 
discharge in log-binomial regression models using purposeful model building.16 The model-
building process was initially undertaken for each variable separately and then adjustments for 
all significant contributing factors (p<0.05) were examined in multivariable models.  
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Results 
Patient characteristics 
There was a total of 6,601 first-ever participants with stroke; with 44% being females (Table 1). 
The median age was 62 years (interquartile range; IQR 53-72), and women generally were about 
5 years older than men (median age 65, IQR 56-75 vs men 60, IQR 52-69; p<0.001). More than 
two-fifths of the patients (42.1%; n=2,779) were current smokers, and the proportion was four 
times greater in men compared to women (62.9% vs 15.7%; p<0,001). We detected 630 patients 
with evidence of atrial fibrillation (86.4%) among 729 cases that were screened for atrial 
fibrillation.  
Stroke severity and stroke type 
The median NIHSS score was 7 points (IQR 4-12). There were 569 cases (8.8%) presenting with 
loss of consciousness (drowsy or comatose) at admission. There were only 34 (0.5%) strokes that 
occurred while in the hospital. The majority of patients were found to have IS (79.9%), followed 
by ICH (18.4%) while only a very small proportion had SAH (1.7%).  
Processes of care 
The median time from stroke onset to hospital arrival was 15.7 hours (IQR 5.6-37.5) and only 
12% of all hospitalized patients with stroke were admitted to hospital ≤ 3.5 hours (Table 1). 
Almost all hospitalized patients with stroke received neuroimaging (98.6%). Among those with 
IS, 257 (4.9%) received carotid investigation ≤7 days after hospital admission. Carotid 
endarterectomy or angioplasty/stenting ≤2 weeks after stroke onset were performed among 30 
out of 345 (8.7%) of the patients with IS eligible for the procedures.  
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Of all patients admitted to the hospital with IS, 9.4% (n=497) were treated with intravenous 
thrombolytic therapy and they were all admitted to hospital ≤ 3.5 hours. Up to 11.6% (n=611) of 
IS cases underwent a recanalization procedure, including intravenous thrombolysis alone 
(n=377), endovascular treatment alone (n=114), or both (n=120). The median door-to-needle 
time for intravenous thrombolysis was 45 minutes (IQR 33-60). 
Approximately one-third of the participants (32.8%) had assessment for rehabilitation needs ≤72 
hours after hospital admission. Of those with ICH, surgical evacuation of the hematoma was 
performed among 17 cases (1.4%) and hemicraniectomy was used in 30 cases (8.7%). Almost all 
patients with stroke (99.5%) received dysphagia assessment/screening. In general, more than 
90% of patients received secondary prevention therapies that were level-1 evidence-based 
processes of care: hypertensive agents (92.2%), cholesterol-lowering medication (IS; 99.0%), 
antithrombotic medication (IS; 97.9%). 
The median length of hospital stay was 3 days (IQR 1-6) among those deceased within hospital 
and 4 days (IQR 3-6) for survivors at discharge. Of all cases, 88.9% were discharged home while 
only 3.1% (n=199) died. The remaining cases were either transferred to another hospital (2.0%), 
rehabilitation centers (5.1%), or long-term care facility/nursing home (1.0%). At discharge, 
nearly half (45.8%; n=2,931) of the survivors were able to walk 10 meters without assistance 
(Table 1). In multivariable models, more advanced age and severe strokes were contributing 
factors to mortality and poorer functional outcome at discharge. Being administered with 
antihypertensive agents was negatively associated with poorer outcomes after stroke (Table 2). 
In addition, the provision of cholesterol-lowering and antithrombotic medications was found to 
be significantly associated with better survival among those with IS (Table 2). There was no 
evidence of statistical interactions between covariates and the investigated outcomes.  
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The evidence-based care performances and discharge outcome varied across our study and some 
selected reports in national stroke registries in other LMICs (Table 3). 
Discussion 
The proportion of patients with IS receiving thrombolysis therapy has substantially increased 
from 0.6% in 2006, 3.2% in 2016 (unpublished data from the 115’s People Hospital) to 9.4% in 
the present study, demonstrating the effort to improve the quality of stroke care at this hospital. 
This thrombolysis rate is greater than that of some selected stroke registries in LMICs  (e.g. Thai 
Stroke Registry: 3.8%;17 Taiwan Stroke Registry: 8.8%18). However, the considerable delay in 
the time from stroke onset to hospital arrival remains an important issue. More than 70% of those 
with stroke admitted to our stroke unit did not arrive ≤3.5 hours after experiencing stroke 
symptoms and they were then potentially ineligible for intravenous thrombolysis therapy. Within 
Vietnam, public misconceptions of stroke and use of inappropriate traditional therapies (e.g. coin 
rubbing) may contribute to delays in seeking acute stroke care in hospitals, limiting the options 
for evidence-based treatments.10 The median door-to-needle time at the hospital, which has 
reduced to 45 minutes, achieved the initial goal recommended by the American Heart 
Association/American Stroke Association’s target (≤ 60 minutes for at least 50% of acute IS 
patients).19 Our ultimate aim should be to continue to improve the door-to-needle times of ≤60 
minutes for all IS, as recommended in current clinical guidelines.12   
Some aspects of care including assessment for rehabilitation needs and carotid investigation 
appeared to be more sub-optimal when compared to other LMICs (Table 3). This suggests a need 
for better understanding of the local barriers and enablers to improving the quality of care in this 
hospital and among other hospitals in Vietnam. For example, according to the China Stroke 
Registry II,20 the reasons for lack of assessment for rehabilitation needs ≤72 hours after hospital 
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admission included the patients’ condition that did not allow for assessment, patients/relative’s 
refusal, and lack of personnel and equipment.  
Outcomes at discharge 
In the current study, in-hospital mortality was at 3.1%, similar to the findings from the previous 
hospital-based cohort at the 115 People’s Hospital (3.1%; 2010)21 and a population-based at a 
provincial hospital in Da Nang City, South-central Vietnam (3.3%; 2010).22 The mortality is 
comparable to that of some national stroke registries in LMICs including Thai Stroke Registry 
(3.2%)17 and Taiwan Stroke Registry (4.0%)18 but lower than the figure in Bahrain (13.4%)23 and 
Malaysia24 (11.1%; Table 3). The low mortality rate is likely due to the short length of hospital 
stay (median: 4 days) and many hospitalized patients may go home to die. In a previous study 
conducted in our ward (2009-2010), the average total costs per stroke admission presented in 
United States (US) dollars were US$963 (including US$560 for direct medical cost).25 Health 
insurance only covered about half of the direct medical costs and the total costs of stroke were 
2.38 times greater than the median household income of the respondents in this study.25 The 
long-term financial impact on families is of concern. Many stroke survivors are reliant on family 
members, many of whom are women (77%), for ongoing care25 and is partly because post-stroke 
rehabilitation services are extremely limited and costly.26 With the increasing numbers of stroke 
in Vietnam,27 and the high-cost burden of treatment, it is important to implement effective 
treatment strategies to reduce the impact of this disease.  
 
We found that processes of care including antihypertensive, cholesterol-lowering and 
antithrombotic medication were associated with better survival and functional outcome. This 
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could be translated that if the hospital could maximize their processes of care, the impact of 
stroke would be reduced. Apart from processes of care, age and stroke severity were found to be 
major predictors of in-hospital mortality and functional outcome. In the present study, stroke 
occured in younger age (approximately 10 years younger) compared to those in HICs. This is 
mostly due to the increased cardiovasular disease risk factors among adults.3 The rate of smoking 
in men is very high compared to that in western countries.28 In this registry, data on other risk 
factors for stroke (such as hypertension, diabetes) were not available, but evidence suggests that 
many people in Vietnam have uncontrolled hypertension, obesity, diabetes and unhealthy diet.7 
This emphasizes the importance to better manage cardiovascular risk factors such as high blood 
pressure, diabetes, or unhealthy behaviors (e.g. smoking, lack of exercise, unhealthy diets) in the 
general population to reduce the burden of stroke. Also, it is imperative to ensure access to 
evidence-based care for all people with stroke to lessen stroke severity and improve outcomes 
after stroke. 
Further recommendations  
There are currently about 1,500 hospitals across Vietnam.29 There are limited resources and 
infrastructure for stroke care and treatment, including shortage of staff with expertise in stroke or 
who are upskilled to manage stroke according to best-practice in hospitals.29 Only fewer than 10 
stroke units are available to service a population of more than 80 million,10 suggesting that the 
vast majority of patients may not receive adequate evidence-based care. Therefore, there is an 
urgent need for more stroke units and improved management of stroke as a medical emergency 
and greater provision of specialized care across the country.  
Strengths and limitations 
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The analyses are based on a large dataset from a 13-month surveillance of 6,601 first-ever 
strokes admitted to the stroke unit of a major public hospital. Our results from high-quality data 
collected through the RES-Q platform, which is used in more than 50 countries,30 will help 
inform future interventions to ensure systematic monitoring of the quality of stroke care and 
patient outcomes in Vietnam, which can guide policy and practice decisions. Since early 2017, 
Vietnam has contributed the greatest number of patients registered in the RES-Q central system 
(n=13,818; 8 Vietnamese hospitals).31 There has been an increasing interest in using RES-Q for 
stroke registration in hospitals all over the world, and some preliminary findings have been 
presented as conference abstracts.32,33  
The 115 People’s Hospital is unique in Vietnam to have leading stroke specialists, and a Stroke 
Unit.34 This can be seen in our study findings that, in our stroke unit, thrombolytic or 
endovascular therapy for acute IS had been undertaken for more than one case per day over the 
13 months. Other limitations include that we were unable to track the survival status if a patient 
chose to die at home. Barriers to RES-Q included the inability to collect data on comorbidities 
(i.e. hypertension, diabetes), and patient outcomes after stroke beyond hospital (i.e. 90 days) and 
in the long term. Because of the cultural preferences for end-of-life care at home in Vietnam,21 
the mortality rate (3.1%) in this study is likely underestimated. Linkage of stroke incidence 
studies to the national death registrations offers a solution for the lack of long-term survival 
information in many HICs.35 However, national registration systems for deaths remain 
uncommon in most LMICs36 including Vietnam.  
Conclusion 
In our study, the considerable delay in the time from stroke onset to hospital arrival is of 
concern, suggesting an essential call for better strategies to increase public awareness for stroke 
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in Vietnam. Most hospitalized patients with acute stroke in the stroke unit within 115 People’s 
Hospital received evidence-based care and have favorable outcomes. To achieve the favourable 
outcomes shown in the major public hospital, more stroke units and greater provision of 
specialized care across Vietnam and other LMICs are crucial.  
Abbreviations 
RES-Q: Registry of Stroke Care Quality. IS: ischemic stroke.   
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Table 1. Characteristic of RES-Q registrants for stroke in the stroke unit in 115 People’s 
Hospital during June 2017-July 2018 by sex  
 n (%) or median (IQR) 
 
 
 Overall Men Women P−value* 
Number of cases 6,601 3,695 (56.0) 2,906 (44.0) <0.001 
Sociodemographics     
Age, median (IQR) 62 (53-72) 60 (52−69) 65 (56−75) <0.001 
Pre-stroke health     
Current smoker 2,779 (42.1) 2,324 (62.9) 455 (15.7) <0.001 
The presence of AF     
Detected by screening 630 (9.5) 284 (7.7) 346 (11.9) <0.001 
Undetected by screening 99 (1.5) 39 (1.1) 60 (2.1)  
Unscreened  5,872 (90.0) 3,372 (91.3) 2,500 (86.0)  
Stroke−related factors     
Stroke severity     
NIHSS, median (IQR)* 7 (4-12) 7 (4-11) 7 (4-12) 0.100 
Loss of consciousness 
(drowsy/comatose) 
569 (8.8) 313 (8.6) 256 (8.9) 0.671 
In−hospital stroke 34 (0.5) 17 (0.5) 17 (0.6) 0.482 
Type of stroke     
Ischemic stroke (IS) 5274 (79.9) 2911 (78.8) 2363 (81.3) 0.023 
Intracerebral hemorrhagic 
(ICH) 
1,217 (18.4) 714 (19.3) 503 (17.3)  
Subarachnoid 
hemorrhagic 
110 (1.7) 70 (1.9) 40 (1.4)  
Processes of care     
Median time to hospital 
(hours)  
15.7 (5.6-37.5) 14.2 (5.4-35.0) 18.5 (5.9-44.0) 0.827 
Time to hospital     
≤ 3.5 hours 794 (12.0) 465 (12.6) 329 (11.3) 0.088 
> 3.5 hours 4,670 (70.8) 2,583 (69.9) 2,087 (71.8)  
Missing  1,137 (17.2) 647 (17.5) 490 (16.9)  
Neuroimaging  6,497 (98.4) 3,695 (98.5) 2,858 (98.4) 0.659 
Carotid investigation ≤7 
days after hospital 
admission (IS) 
257 (4.9) 126 (4.3) 131 (5.5) 0.041 
Carotid endarterectomy or 
angioplasty/stenting ≤2 
weeks after stroke onset 
(IS) 
30 (8.7) 20 (8.1) 10 (10.2) 0.531 
Intravenous thrombolysis 
(tPA; all cases) 
497 (7.5%) 290 (7.9) 207 (7.1) 0.268 
Intravenous thrombolysis 
(tPA; IS and admission 
time ≤3.5 hours) 
497 (9.4%) 290 (10.0) 207 (8.8) 0.137 
Recanalization procedures 
(IS) 
611 (11.6) 349 (12.0) 262 (11.0) 0.309 
tPA alone 377 (7.2)    
tPA + endovascular 
treatment 
120 (2.2)    
endovascular treatment 
alone 
114 (2.2)    
No 4,633 (88.4)    
Time to needle (mins, IQR) 45 (33-60) 45 (30-60) 45 (34-60) 1.000 
Assessment for 
rehabilitation needs ≤72 
hours after hospital 
admission 
2,166 (32.8) 1,155 (31.3) 1,011 (34.8) 0.002 
Surgical thrombectomy 
(ICH) 
17 (1.4) 13 (1.8) 4 (0.8) 0.133 
Hemicraniectomy (ICH) 30 (8.7) 20 (8.1) 10 (10.2) 0.531 
Dysphagia screening 6,565 (99.5) 3,672 (99.4) 2,893 (99.6) 0.338 
Dysphagia screening (IS) 5,241 (99.4) 2,980 (99.3) 2,351 (99.5) 0.328 
Antihypertensive agent† 5,902 (92.2) 3,299 (91.8) 2,603 (92.7) 0.179 
Cholesterol-lowering 
medication† 
5,071 (79.2) 2,808 (78.1) 2,263 (80.6) 0.016 
Cholesterol-lowering 
medication (IS)† 
5,071 (99.0) 2,808 (99.0) 2,263 (99.0) 0.954 
Antithrombotic medication 
(IS)† 
5,016 (97.9) 2,771 (97.7) 2,245 (98.2) 0.185 
Discharge information     
LOS if discharged, median 
(IQR) 
3 (1-6) 3 (1-5) 3 (1-7) 0.781 
LOS if deceased, median 
(IQR) 
4 (3-6) 4 (3-6) 4 (3-6) 0.100 
Discharge destination     
Home 5,869 (88.9) 3,275 (88.6) 2,594 (89.2) 0.139 
Rehabilitation facility 334 (5.1) 197 (5.3) 137 (4.7)  
Long-term care 
facility/nursing home 
66 (1.0) 44 (1.2) 22 (0.8)  
Other hospital 133 (2.0) 78 (2.1) 55 (1.9)  
Died 199 (3.1) 101 (2.7) 98 (3.4)  
Able to walk 10 meters 
without assistance† 
2,931 (45.8) 1,688 (47.0) 1,243 (44.3) 0.031 
Length of stay: LOS. IQR: Interquartile range. Of note, missing data on processes of care 
were coded as not receiving the corresponding therapy 
*missing data <10% 
†among those discharged 
 
  
Table 2. Predictors of outcomes at discharge in univariable and multivariable models* 
 
Covariate In-hospital mortality Poorer functional outcome  
 Univariable 
model 
Multivariable 
model 
Univariable 
model 
Multivariable 
model 
 RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI) 
Model 1 (All 
strokes) 
    
Age 1.04 (1.03-
1.05) 
1.02 (1.01-
1.03) 
1.01 (1.00-
1.01) 
1.00 (1.00-
1.01) 
NIHSS 1.18 (1.16-
1.20) 
1.10 (1.08-
1.12) 
1.08 (1.08-
1.09) 
1.08 (1.08-
1.09) 
Antihypertensive 
agent(s) 
0.01 (0.01-
0.02) 
0.02 (0.01-
0.04) 
1.13 (0.99-
1.28) 
1.14 (1.00-
1.31) 
Model 2 (Ischemic 
strokes) 
    
Age 1.05 (1.03-
1.07) 
ns 1.01 (1.00-
1.01) 
1.01 (1.00-
1.01) 
NIHSS 1.18 (1.16-
1.20) 
ns 1.08 (1.08-
1.09) 
1.08 (1.08-
1.09) 
Antihypertensive 
agent(s) 
0.01 (0.006-
0.02)  
0.30 (0.14-
0.63) 
1.02 (0.89-
1.17) 
ns 
Cholesterol-lowering 
medication 
0.002 (0.001-
0.004) 
0.02 (0.006-
0.06) 
0.66 (0.49-
0.91) 
ns 
Antithrombotic 
medication 
0.004 (0.002-
0.007) 
0.23 (0.09-
0.61) 
0.67 (0.53-
0.83) 
ns 
RR: relative risk; CI: confidence interval; not significant; NIHSS: National Institute of 
Health Stroke Scale, ns: not statistically significant (p<0.05)  
*Only significant variables (p<0.05) were retained in the multivariable models  
 
  
 
Figure 1. Evidence-based care received in the stroke unit in 115 People’s Hospital among hospitalized patients with acute stroke during Jun 
2017 and Mar 2018 registered in the RES-Q 
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Table 3. Characteristic of RES-Q registrants for stroke in the 115 People’s Hospital compared with other stroke registries from selected low- and 
middle-income countries  
 RES-Q 
Vietnam 
(n=6,601) 
Thai Stroke 
Registry1 
(n=1,222) 
China Stroke 
Registry II2 
(n=19,294) 
Bahrain3 
(n=521) 
National Stroke 
Registry (Malaysia; 
n=1,018)4 
Taiwan Stroke Registry5 
(n=30,599) 
Year Jun 17-Jul 18 Jun 08 – Nov 
10 
Jun 12 – Jan 13 2011 Aug 09 – Dec 10 06-08 
Women (%) 44  45 37 34 46 40 
Sociodemographics       
Age, median (IQR); or 
mean (SD)  
62 (53-72) mean: 65.0 
(13.0) 
65 (57-74) mean: 60.5 
(na) 
mean: 62.5 (na) 70 (60-78)† 
Pre-stroke health       
Current smoker (%) 42.1  44.2   40.4† 
Atrial fibrillation (AF; %) 9.5  7.1   16.5† 
Stroke−related factors       
Stroke severity       
NIHSS, median (IQR)* 7 (4-12) 6.5 (3-12) 4 (2-7)   5 (2-9)† 
Loss of consciousness 
(drowsy/comatose; %) 
8.8   32.6   
Type of stroke (%)       
Ischemic stroke (IS) 79.9 100 100 60.0 73.3 74.0 
Intracerebral 
hemorrhagic (ICH) 
18.4 excluded excluded 20.0 20.9 16.1 
Subarachnoid 
hemorrhagic 
1.7 excluded excluded 3.0 1.7 2.8 
Processes of care (%)       
Neuroimaging  98.4 100  88.2  92.1† 
Stroke unit access 100.0 24.6      
Carotid imaging before 
discharge (IS) 
4.9 (≤7 days) 13.1 67.0 34.7   
Intravenous thrombolysis 
(IS; %) 
9.4 3.8    8.8 
Assessment for 
rehabilitation needs ≤72 
hours after hospital 
admission (%) 
32.8  64.8 (before 
discharge) 
52.8   
Dysphagia screening 99.5  84.4 20.3 (≤24 
hours) 
83.0  
Antihypertensive agent* 92.2 31.0  79.0   
Cholesterol-lowering 
medication* 
79.2 73.4  82.0 87.0  
Cholesterol-lowering 
medication* (IS) 
99.0     38.7 
Antithrombotic 
medication (IS)* 
97.9  65.9 83.0 38.6 94.1 
Aspirin administration≤48 
hours 
   82.3 85.7  
Antiplatelet agent(s) at 
discharge 
 80.1   84.4 85.5 
Anticoagulants if AF  39.8   39.4 28.3 
Discharge information       
Length of stay, median 
(IQR) 
4 (3-6) 4 (3-7) 13 (9-16)   8 (5-15)† 
Length of stay, mean (SD)   15.4 (?) 5.1 (?)  
In-hospital mortality (%) 3.1 3.2  13.4 11.1 4.0† 
na: not available; SD: standard deviation; IQR: interquartile range 
*among those discharged 
†among IS  
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